#1 Clinical Trials Search in Europe

Fluorometholone

This article examines the use of Fluorometholone, a corticosteroid eye medication, in various clinical trials for ophthalmic conditions. Fluorometholone is being studied for its potential benefits in treating dry eye disease, preventing corneal transplant rejection, managing ocular rosacea, and as a post-operative treatment for eye surgeries. The trials aim to evaluate its efficacy, safety, and compare it to other treatments.

Table of Contents

What is Fluorometholone?

Fluorometholone, also known as FML, is a type of corticosteroid medication used in ophthalmology (eye care)[1]. It belongs to a class of drugs called steroids, which are used to reduce inflammation in various parts of the body, including the eyes[2]. Fluorometholone is typically administered as eye drops and is used to treat various eye conditions characterized by inflammation.

Uses of Fluorometholone

Fluorometholone is prescribed for several eye conditions, including:

  • Dry Eye Disease: It can be used to treat the inflammatory component of dry eye disease, also known as keratoconjunctivitis sicca[3].
  • Post-Surgical Inflammation: It’s often used after eye surgeries such as photorefractive keratectomy (PRK) to reduce inflammation and promote healing[1].
  • Corneal Transplant: Fluorometholone can be part of a treatment regimen to prevent rejection after corneal transplant surgeries[2].
  • Ocular Rosacea: It may be used in the treatment of ocular rosacea, a condition that causes eye redness and irritation[4].
  • Viral Keratitis: In some cases, it’s used as part of the treatment for viral infections of the cornea, such as herpes simplex keratitis[5].

How Fluorometholone Works

Fluorometholone works by reducing inflammation in the eye. When applied, it suppresses the body’s immune response in the affected area, which helps to decrease redness, swelling, and irritation. This can lead to symptom relief and improved healing in various eye conditions[3].

Administration and Dosage

Fluorometholone is typically administered as eye drops. The dosage can vary depending on the condition being treated, but common regimens include:

  • Four times a day for the first week
  • Three times a day for the second week
  • Twice a day for the third week
  • Once a day for the fourth week

This gradual tapering helps to control inflammation while minimizing potential side effects[2]. However, always follow your doctor’s specific instructions, as dosages may vary based on individual needs and conditions.

Comparison with Other Medications

Fluorometholone is often compared to other corticosteroid eye drops and anti-inflammatory medications:

  • Prednisolone: Fluorometholone is generally considered to have a lower risk of increasing eye pressure compared to prednisolone, another commonly used steroid eye drop[2].
  • Loteprednol: This is another steroid eye drop that, like fluorometholone, is designed to have a lower risk of increasing eye pressure[1].
  • Cyclosporine: In some studies, fluorometholone has been compared to cyclosporine for treating certain eye conditions. Both medications work to reduce inflammation, but through different mechanisms[6].

Potential Side Effects

While fluorometholone is generally well-tolerated, it can have some side effects. These may include:

  • Increased Intraocular Pressure: This is a potential side effect of all steroid eye drops, although fluorometholone may have a lower risk compared to some other steroids[3].
  • Cataract Formation: Long-term use of steroid eye drops can increase the risk of cataract formation[2].
  • Eye Irritation: Some patients may experience temporary burning or stinging when applying the drops[3].
  • Delayed Wound Healing: In some cases, steroid eye drops can slow down the healing process of the eye’s surface[1].

It’s important to use fluorometholone under the supervision of an eye care professional and report any unusual symptoms or side effects.

Ongoing Research

Researchers continue to study fluorometholone to better understand its effects and potential uses. Some areas of ongoing research include:

  • Comparing fluorometholone to newer treatments for dry eye disease[3].
  • Evaluating its effectiveness in preventing corneal transplant rejection[2].
  • Studying its use in combination with other medications for various eye conditions[4].
  • Investigating its role in treating viral eye infections[5].

These ongoing studies aim to improve our understanding of fluorometholone and optimize its use in eye care.

Condition Trial Purpose Comparison Treatment Key Outcomes Measured
Post-PRK Treatment Compare Fluorometholone to Loteprednol Loteprednol (Lotemax) Time to re-epithelialization, pain reduction, occurrence of enhancements
Corneal Transplant Rejection Prevention Compare Fluorometholone to Prednisolone acetate Prednisolone acetate 1% Solution Number of graft rejection episodes, intraocular pressure elevation
Ocular Rosacea Compare Fluorometholone to Dextenza insert Dextenza (dexamethasone) 0.4mg insert Change in tear break-up time, corneal staining, patient preference
Epidemic Keratoconjunctivitis Compare Fluorometholone to Cyclosporine A Cyclosporine A 0.5% eye drops Change in subepithelial infiltrates, visual acuity, clinical score
Dry Eye Disease Evaluate Fluorometholone efficacy Artificial tears (placebo) Changes in corneal staining, symptom scores, tear inflammatory molecules
Trachomatous Trichiasis Surgery Evaluate Fluorometholone as adjunctive therapy Artificial tears (placebo) Incidence of postoperative trachomatous trichiasis, adverse events

FAQ

  • What is Fluorometholone used for in these clinical trials? Fluorometholone is being studied for various ophthalmic conditions including dry eye disease, prevention of corneal transplant rejection, management of ocular rosacea, and as a post-operative treatment for eye surgeries like photorefractive keratectomy (PRK) and trachomatous trichiasis surgery.
  • How is Fluorometholone administered in these trials? Fluorometholone is typically administered as eye drops. The dosage and frequency vary depending on the condition being treated, but common regimens include 4 times daily for 1 month, then tapering to 3 times daily, 2 times daily, and once daily over several months.
  • What are some potential benefits of Fluorometholone observed in these trials? Potential benefits include reduction of inflammation, improvement in dry eye symptoms, prevention of corneal transplant rejection, management of ocular rosacea symptoms, and better post-operative outcomes in eye surgeries.
  • Are there any side effects or safety concerns associated with Fluorometholone use? While generally well-tolerated, some trials monitor for potential side effects such as increased intraocular pressure, corneal ulceration, and cataract formation. Safety assessments are a key component of these clinical trials.
  • How does Fluorometholone compare to other treatments in these trials? Several trials compare Fluorometholone to other treatments such as cyclosporine, artificial tears, and different corticosteroid regimens. The aim is to determine if Fluorometholone is more effective, equally effective, or has a better safety profile compared to these alternatives.

Ongoing Clinical Trials on Fluorometholone

  • Study on Dexamethasone and Fluorometholone for Patients Undergoing Corneal Transplantation

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands

Glossary

  • Fluorometholone: A corticosteroid medication used in eye drops to treat inflammation of the eye.
  • Photorefractive keratectomy (PRK): A type of laser eye surgery used to correct myopia, hyperopia, and astigmatism by reshaping the cornea.
  • Trachomatous trichiasis: A condition where eyelashes turn inward and touch the eye, often caused by trachoma infection.
  • Ocular rosacea: An inflammatory condition affecting the eyes, often associated with facial rosacea.
  • Keratoconjunctivitis sicca: Another term for dry eye disease, characterized by insufficient tear production or rapid tear evaporation.
  • Intraocular pressure (IOP): The fluid pressure inside the eye, which is monitored as a safety measure in many eye treatments.
  • Corneal transplant rejection: A complication where the body's immune system attacks the transplanted corneal tissue.
  • Subepithelial infiltrates (SEIs): Small, inflammatory lesions that can form beneath the surface layer of the cornea, often as a result of viral infections.
  • Schirmer test: A diagnostic procedure used to measure the production of tears.
  • Tear break-up time (TBUT): A test that measures the stability of the tear film on the surface of the eye.

References

  1. https://clinicaltrials.gov/study/NCT02974387
  2. https://clinicaltrials.gov/study/NCT01448213
  3. https://clinicaltrials.gov/study/NCT02051023
  4. https://clinicaltrials.gov/study/NCT04839549
  5. https://clinicaltrials.gov/study/NCT05313828
  6. https://clinicaltrials.gov/study/NCT04376970